non hematologic toxicities

Related by string. * nOn . nons . NON . - - Non : Non GAAP Financial . non farm payrolls . Non Aligned Movement NAM . Non GAAP net / Hematologic : hematologic toxicity correlated . hematologic toxicity . hematologic malignancies . Hematologic Malignancies / Toxicities : ERBITUX dermatologic toxicities . hematologic toxicities . non hematological toxicities . hematological toxicities * *

Related by context. Frequent words. (Click for all words.) 68 hematologic toxicity 66 laboratory abnormalities 64 sensory neuropathy 57 % CI #.#-#.# [007] 57 QTc prolongation 56 hypomagnesemia 55 CIMZIA TM 55 univariate analysis 54 corticosteroid therapy 54 lymphopenia 53 patients evaluable 52 % CI #.#-#.# [003] 52 μg kg 51 IIb 51 resectable 51 radical nephrectomy 51 clinically meaningful improvement 51 NYHA Class II 50 50 univariate 50 lymphadenectomy 50 deferoxamine 50 posttreatment 50 astrocytoma 50 Psoriasis Area 50 hyperparathyroidism 50 FOLFOX4 50 HSCT 49 D dimer 49 EBRT 49 P = .# 49 pneumonitis 49 myelodysplastic syndrome MDS 49 mRCC 49 HIV uninfected 49 3mg 49 IGFBP 3 49 apolipoprotein B 49 IIIA 49 lactulose 49 LUTS 48 extrapyramidal symptoms 48 prepubertal 48 Thrombolysis 48 mycophenolate mofetil 48 STELARA 48 Aripiprazole 48 ADAS cog 48 ACR# response 48 chemoradiotherapy 48 preoperatively 48 Pioglitazone 48 haematological 48 Postoperative 48 Arch Intern Med 48 prespecified 48 evaluable 48 relapsing multiple sclerosis 48 locoregional 48 Malignancies 48 bleomycin 47 IIIB 47 postoperatively 47 recurrent glioblastoma 47 Capecitabine 47 RECIST criteria 47 placebo p = 47 Glioma 47 biochemical recurrence 47 elevated LDL 47 Monotherapy 47 IPSS 47 Pediatric Patients 47 #,#,#,# [004] 47 Dasatinib 46 Immunogenicity 46 C1 C2 46 ANOVA 46 fasting insulin 46 lymph node metastases 46 intra arterial 46 Unified Parkinson Disease 46 squamous 46 Kaplan Meier 46 J Am Soc 46 Benign Prostatic Hyperplasia 46 J Clin Oncol 46 Grade 46 Main Outcome Measures 46 1mg 46 Pivotal Phase 46 Single Dose 45 complete cytogenetic 45 primary percutaneous coronary 45 prospectively defined 45 NYHA Class III 45 multivariate analyzes 45 covariate 45 radical cystectomy 45 interquartile range 45 MR spectroscopy

Back to home page